Sort   by:  
 Page size 
Overcoming endocrine-resistance is the major challenge in treating Estrogen receptor (ER)-positive breast cancer. Breast Cancer Stem Cells (BCSCs) are blamed to be the driving force behind poor clinical outcomes and therapeutic resistance. Tumor microenvironment (TME) exerts a selective pressure on ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD059964 | Pride
Sort   by:  
 Page size